AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
MULTIDRUG-RESISTANCE MODULATION IN RHABDOMYOSARCOMA AND NEUROBLASTOMACELL-LINES
Authors: COWIE FJ PRITCHARDJONES K RENSHAW J PINKERTON CR
Citation: Fj. Cowie et al., MULTIDRUG-RESISTANCE MODULATION IN RHABDOMYOSARCOMA AND NEUROBLASTOMACELL-LINES, International journal of oncology, 12(5), 1998, pp. 1143-1149
NON-HODGKINS-LYMPHOMA - COMMENTARY
Authors: PINKERTON CR
Citation: Cr. Pinkerton, NON-HODGKINS-LYMPHOMA - COMMENTARY, European journal of cancer, 34(3), 1998, pp. 362-363
DEOXYURIDINE PLASMA-LEVELS DURING THE PHASE-I STUDY OF NOLATREXED IN CHILDREN WITH ADVANCED CANCER
Authors: TAYLOR GA ESTLIN EJ PINKERTON CR GOWING R LASHFORD L MORLAND B LEWIS IJ NEWELL DR BODDY AV JOHNSTON A PEARSON ADJ
Citation: Ga. Taylor et al., DEOXYURIDINE PLASMA-LEVELS DURING THE PHASE-I STUDY OF NOLATREXED IN CHILDREN WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 618-618
TOLERABILITY OF AMPHOTERICIN-B LIPID COMPLEX (ABELCET) IN CHILDREN WITH MALIGNANT DISEASE
Authors: CHISHOLM JC DEVINE T MYCROFT J PINKERTON CR
Citation: Jc. Chisholm et al., TOLERABILITY OF AMPHOTERICIN-B LIPID COMPLEX (ABELCET) IN CHILDREN WITH MALIGNANT DISEASE, Bone marrow transplantation, 21, 1998, pp. 502-502
2ND CANCERS AND NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES - SINGLE-CENTER EXPERIENCE OF 883 PATIENTS
Authors: KULKARNI S POWLES R SINGHAL S TRELEAVEN J HORTON C MELLER S PINKERTON CR ATRA A TAIT D MEHTA J
Citation: S. Kulkarni et al., 2ND CANCERS AND NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES - SINGLE-CENTER EXPERIENCE OF 883 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 563-563
MINIMAL RESIDUAL DISEASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: CATOVSKY D FARAHAT N MATUTES E POWLES RL PINKERTON CR
Citation: D. Catovsky et al., MINIMAL RESIDUAL DISEASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Lancet, 351(9111), 1998, pp. 1287-1287
CONSERVATIVE MANAGEMENT OF FOLLICULAR NON-HODGKINS-LYMPHOMA IN CHILDHOOD
Authors: ATRA A MELLER ST STEVENS RS HOBSON R GRUNDY R CARTER RL PINKERTON CR
Citation: A. Atra et al., CONSERVATIVE MANAGEMENT OF FOLLICULAR NON-HODGKINS-LYMPHOMA IN CHILDHOOD, British Journal of Haematology, 103(1), 1998, pp. 220-223
2ND CANCERS AFTER NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: KULKARNI S POWLES R SINGHAL S MEHTA J TRELEAVEN J HORTON C MELLER S PINKERTON CR ATRA A TAIT D
Citation: S. Kulkarni et al., 2ND CANCERS AFTER NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, British Journal of Haematology, 102(1), 1998, pp. 211-211
DETECTION OF MINIMAL RESIDUAL DISEASE IN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA BY QUANTITATIVE FLOW-CYTOMETRY
Authors: FARAHAT N MORILLA A OWUSUANKOMAH K MORILLA R PINKERTON CR TRELEAVEN JG MATUTES E POWLES RL CATOVSKY D
Citation: N. Farahat et al., DETECTION OF MINIMAL RESIDUAL DISEASE IN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA BY QUANTITATIVE FLOW-CYTOMETRY, British Journal of Haematology, 101(1), 1998, pp. 158-164
PHASE-I STUDY OF TEMOZOLOMIDE IN PEDIATRIC-PATIENTS WITH ADVANCED CANCER
Authors: ESTLIN EJ LASHFORD L ABLETT S PRICE L GOWING R GHOLKAR A KOHLER J LEWIS IJ MORLAND B PINKERTON CR STEVENS R MOTT M STEVENS R NEWELL DR WALKER D DICKSMIREAUX C MCDOWELL H REIDENBERG P STATKEVICH P MARCO A BATRA V DUGAN N PEARSON ADJ
Citation: Ej. Estlin et al., PHASE-I STUDY OF TEMOZOLOMIDE IN PEDIATRIC-PATIENTS WITH ADVANCED CANCER, British Journal of Cancer, 78(5), 1998, pp. 652-661
VALIDATION OF PHARMACOLOGICALLY-GUIDED DOSING OF CARBOPLATIN IN PEDIATRIC-PATIENTS
Authors: THOMAS HD BODDY AV PEARSON ADJ PINKERTON CR LEWIS I STEVENS M IMESON J HOBSON R NEWELL DR
Citation: Hd. Thomas et al., VALIDATION OF PHARMACOLOGICALLY-GUIDED DOSING OF CARBOPLATIN IN PEDIATRIC-PATIENTS, British Journal of Cancer, 78, 1998, pp. 22-22
IMPROVED CURE RATE IN CHILDREN WITH B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (B-ALL) AND STAGE-IV B-CELL NON-HODGKINS-LYMPHOMA (B-NHL) - RESULTSOF THE UKCCSG-9003 PROTOCOL
Authors: ATRA A GERRARD M HOBSON R IMESON JD ASHLEY S PINKERTON CR
Citation: A. Atra et al., IMPROVED CURE RATE IN CHILDREN WITH B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (B-ALL) AND STAGE-IV B-CELL NON-HODGKINS-LYMPHOMA (B-NHL) - RESULTSOF THE UKCCSG-9003 PROTOCOL, British Journal of Cancer, 77(12), 1998, pp. 2281-2285
HIGH-DOSE CYCLOSPORINE WITH ETOPOSIDE - TOXICITY AND PHARMACOKINETIC INTERACTION IN CHILDREN WITH SOLID TUMORS
Authors: BISOGNO G COWIE F BODDY A THOMAS HD DICK G PINKERTON CR
Citation: G. Bisogno et al., HIGH-DOSE CYCLOSPORINE WITH ETOPOSIDE - TOXICITY AND PHARMACOKINETIC INTERACTION IN CHILDREN WITH SOLID TUMORS, British Journal of Cancer, 77(12), 1998, pp. 2304-2309
MULTIDRUG-RESISTANCE IN CHILDHOOD SOLID TUMORS
Authors: PINKERTON CR
Citation: Cr. Pinkerton, MULTIDRUG-RESISTANCE IN CHILDHOOD SOLID TUMORS, International journal of pediatric hematology/oncology, 4(6), 1997, pp. 629-637
MALIGNANT GERM-CELL TUMORS IN CHILDHOOD
Authors: PINKERTON CR
Citation: Cr. Pinkerton, MALIGNANT GERM-CELL TUMORS IN CHILDHOOD, European journal of cancer, 33(6), 1997, pp. 895-901
PHASE-II STUDY OF 21-DAY SCHEDULE ORAL ETOPOSIDE IN CHILDREN
Authors: DAVIDSON A GOWING R LOWIS S NEWELL D LEWIS I DICKSMIREAUX C PINKERTON CR
Citation: A. Davidson et al., PHASE-II STUDY OF 21-DAY SCHEDULE ORAL ETOPOSIDE IN CHILDREN, European journal of cancer, 33(11), 1997, pp. 1816-1822
CYTOMEGALOVIREMIA AFTER AUTOGRAFTING FOR LEUKEMIA - CLINICAL-SIGNIFICANCE AND LACK OF EFFECT ON ENGRAFTMENT
Authors: SINGHAL S POWLES R TRELEAVEN J HORTON C PINKERTON CR MELLER S MEHTA J
Citation: S. Singhal et al., CYTOMEGALOVIREMIA AFTER AUTOGRAFTING FOR LEUKEMIA - CLINICAL-SIGNIFICANCE AND LACK OF EFFECT ON ENGRAFTMENT, Leukemia, 11(6), 1997, pp. 835-838
DOES HISTOLOGY INFLUENCE OUTCOME IN CHILDHOOD HODGKINS-DISEASE - RESULTS FROM THE UNITED-KINGDOM CHILDRENS CANCER STUDY-GROUP
Authors: SHANKAR AG ASHLEY S RADFORD M BARRETT A WRIGHT D PINKERTON CR
Citation: Ag. Shankar et al., DOES HISTOLOGY INFLUENCE OUTCOME IN CHILDHOOD HODGKINS-DISEASE - RESULTS FROM THE UNITED-KINGDOM CHILDRENS CANCER STUDY-GROUP, Journal of clinical oncology, 15(7), 1997, pp. 2622-2630
GRANULOCYTE-COLONY-STIMULATING FACTOR IN ESTABLISHED FEBRILE NEUTROPENIA - A RANDOMIZED STUDY OF PEDIATRIC-PATIENTS
Authors: MITCHELL PLR MORLAND B STEVENS MCG DICK G EASLEA D MEYER LC PINKERTON CR
Citation: Plr. Mitchell et al., GRANULOCYTE-COLONY-STIMULATING FACTOR IN ESTABLISHED FEBRILE NEUTROPENIA - A RANDOMIZED STUDY OF PEDIATRIC-PATIENTS, Journal of clinical oncology, 15(3), 1997, pp. 1163-1170
HIGH-DOSE BUSULPHAN MELPHALAN WITH AUTOLOGOUS STEM-CELL RESCUE IN EWINGS-SARCOMA/
Authors: ATRA A WHELAN JS CALVAGNA V SHANKAR AG ASHLEY S SHEPHERD V SOUHAMI RL PINKERTON CR
Citation: A. Atra et al., HIGH-DOSE BUSULPHAN MELPHALAN WITH AUTOLOGOUS STEM-CELL RESCUE IN EWINGS-SARCOMA/, Bone marrow transplantation, 20(10), 1997, pp. 843-846
OUTCOME OF ACUTE-LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION- UTILITY OF 2ND TRANSPLANTS AND ADOPTIVE IMMUNOTHERAPY
Authors: MEHTA J POWLES R TRELEAVEN J HORTON C MELLER S PINKERTON CR SINGHAL S
Citation: J. Mehta et al., OUTCOME OF ACUTE-LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION- UTILITY OF 2ND TRANSPLANTS AND ADOPTIVE IMMUNOTHERAPY, Bone marrow transplantation, 19(7), 1997, pp. 709-719
EARLY IDENTIFICATION OF PATIENTS AT RISK OF DEATH DUE TO INFECTIONS, HEMORRHAGE, OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION ON THE BASIS OF THE LEUKOCYTE COUNTS
Authors: MEHTA J POWLES R SINGHAL S HORTON C MIDDLETON G EISEN T MELLER S PINKERTON CR TRELEAVEN J
Citation: J. Mehta et al., EARLY IDENTIFICATION OF PATIENTS AT RISK OF DEATH DUE TO INFECTIONS, HEMORRHAGE, OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION ON THE BASIS OF THE LEUKOCYTE COUNTS, Bone marrow transplantation, 19(4), 1997, pp. 349-355
LUNG INVOLVEMENT IN NEUROBLASTOMA - INCIDENCE AND CHARACTERISTICS
Authors: COWIE F CORBETT R PINKERTON CR
Citation: F. Cowie et al., LUNG INVOLVEMENT IN NEUROBLASTOMA - INCIDENCE AND CHARACTERISTICS, Medical and pediatric oncology, 28(6), 1997, pp. 429-432
A RANDOMIZED COMPARISON OF LIPOSOMAL VERSUS CONVENTIONAL AMPHOTERICIN-B FOR THE TREATMENT OF PYREXIA OF UNKNOWN ORIGIN IN NEUTROPENIC PATIENTS
Authors: PRENTICE HG HANN IM HERBRECHT R AOUN M KVALOY S CATOVSKY D PINKERTON CR SCHEY SA JACOBS F OAKHILL A STEVENS RF DARBYSHIRE PJ GIBSON BES
Citation: Hg. Prentice et al., A RANDOMIZED COMPARISON OF LIPOSOMAL VERSUS CONVENTIONAL AMPHOTERICIN-B FOR THE TREATMENT OF PYREXIA OF UNKNOWN ORIGIN IN NEUTROPENIC PATIENTS, British Journal of Haematology, 98(3), 1997, pp. 711-718
DONOR LYMPHOCYTE INFUSION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION
Authors: ATRA A MILLAR B SHEPHERD V SHANKAR A WILSON K TRELEAVEN J PRITCHARDJONES K MELLER ST PINKERTON CR
Citation: A. Atra et al., DONOR LYMPHOCYTE INFUSION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 97(1), 1997, pp. 165-168
Risultati: 1-25 | 26-50 | 51-69